?
Cannon Kara
Chief Executive Officer
Enzo Biochem, Inc.
US, New York [HQ]
CIK
1913009
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
15,100
Price per Share :
$0.70
Equivalence :
$10,570.00
Transaction History
-
A15,100 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/28/22
-
Footnotes
-
-
Footnotes:#1 The shares of Common Stock were received for no consideration upon the vesting of performance share units granted to the Reporting Person on October 15, 2019.
-
P2,500 Shares After TransactionValue : $6,050.00$6,050.00Transaction Date : 07/15/22
-
Footnotes
-
-
Footnotes:No footnote found.
-
M307,120 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/21/24
-
Footnotes
-
-
Footnotes:#1 Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.#2 Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements.#3 The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control.
-
F301,297 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/21/24
-
Footnotes
-
-
Footnotes:#1 Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.#2 Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements.#3 The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control.
-
A451,297 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.#2 Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements.#3 The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control.